Skip to main content
. 2019 Mar 29;83(6):1175–1181. doi: 10.1007/s00280-019-03820-7

Table 2.

Treatment-related adverse events. LVEF: left ventricle ejection fraction. HTA: hypertension

Adverse events Grade I Grade II Grade III Grade IV
n % n % n % n %
LVEF reduction 0 0 2 4.4 0 0 0 0
HTA 1 2.2 1 2.2 0 0 0 0
Heart failure 0 0 0 0 1 2.2 0 0
Hand–foot syndrome 5 11.1 0 0 1 2.2 0 0
Fatigue 13 28.9 13 28.9 6 13.3 1 2.2
Diarrhoea 4 8.9 8 17.8 11 24.4 1 2.2
Nausea 4 8.9 8 17.8 8 17.8 1 2.2
Vomiting 8 17.8 3 6.7 6 13.3 0 0
Mucositis 2 4.4 3 6.7 1 2.2 0 0
Hyporexia 4 8.9 1 2.2 1 2.2 0 0
Anaemia 11 24.4 5 11.1 1 2.2 0 0
Neutropenia 3 6,7 6 13.3 1 2.2 0 0
Thrombocytopenia 7 15.5 5 11.1 0 0 0 0
Neurotoxicity 22 48.8 12 26.6 1 2.2 0 0